Organogenesis Holdings Inc
ORGO3.060USD
-2.280-42.70%
Cierre 05/09, 16:00（ET）Cotizaciones retrasadas 15 min
388.17MCap. mercado
PérdidaP/E TTM
Más Datos de Organogenesis Holdings Inc Compañía
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.
Información de la empresa
Código de la empresaORGO
Nombre de la empresaOrganogenesis Holdings Inc
Fecha de salida a bolsaDec 02, 2016
Fundada en2018
Director ejecutivoMr. Gary S. Gillheeney, Sr.
Número de empleados869
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 02
Dirección85 Dan Rd
CiudadCANTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02021-2810
Teléfono17815750775
Sitio Webhttps://investors.organogenesis.com
Código de la empresaORGO
Fecha de salida a bolsaDec 02, 2016
Fundada en2018
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
11.91M
--
Mr. Alan A. Ades
Mr. Alan A. Ades
Director
Director
11.19M
--
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
487.05K
+40.33%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
253.50K
+144.18%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
208.85K
+148.85%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Mr. Arthur S. Leibowitz, CPA
Mr. Arthur S. Leibowitz, CPA
Lead Independent Director
Lead Independent Director
186.17K
+36.29%
Ms. Prathyusha Duraibabu, CPA
Ms. Prathyusha Duraibabu, CPA
Independent Director
Independent Director
143.42K
+52.83%
Mr. Jon L. Giacomin
Mr. Jon L. Giacomin
Independent Director
Independent Director
139.41K
+55.19%
Dr. Gilberto Quintero, Ph.D.
Dr. Gilberto Quintero, Ph.D.
Independent Director
Independent Director
139.22K
+55.30%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Glenn H. Nussdorf
Mr. Glenn H. Nussdorf
Director
Director
11.91M
--
Mr. Alan A. Ades
Mr. Alan A. Ades
Director
Director
11.19M
--
Mr. Patrick Bilbo
Mr. Patrick Bilbo
Chief Operating Officer
Chief Operating Officer
487.05K
+40.33%
Mr. Brian Grow
Mr. Brian Grow
Chief Commercial Officer
Chief Commercial Officer
253.50K
+144.18%
Mrs. Lori Freedman, J.D.
Mrs. Lori Freedman, J.D.
Chief Administrative and Legal Officer
Chief Administrative and Legal Officer
208.85K
+148.85%
Mr. Antonio S. Montecalvo
Mr. Antonio S. Montecalvo
Vice President - Health Policy
Vice President - Health Policy
188.20K
+17.78%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
453.64M
94.11%
Surgical & Sports Medicine
28.40M
5.89%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Advanced Wound Care
453.64M
94.11%
Surgical & Sports Medicine
28.40M
5.89%
Accionista
Hora de actualización: lun., 5 de may
Hora de actualización: lun., 5 de may
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Soleus Capital Management, L.P.
9.84%
Nussdorf (Glenn H)
9.39%
Morgan Stanley & Co. LLC
9.26%
Ades (Alan A)
8.82%
Erani (Dennis)
7.92%
Other
54.77%
Estadísticas de accionistas
Accionista
Proporción
Soleus Capital Management, L.P.
9.84%
Nussdorf (Glenn H)
9.39%
Morgan Stanley & Co. LLC
9.26%
Ades (Alan A)
8.82%
Erani (Dennis)
7.92%
Other
54.77%
Tipo
Accionista
Proporción
Individual Investor
32.67%
Investment Advisor/Hedge Fund
15.21%
Corporation
14.12%
Hedge Fund
12.51%
Research Firm
10.79%
Investment Advisor
9.42%
Sovereign Wealth Fund
0.38%
Pension Fund
0.17%
Bank and Trust
0.07%
Other
4.66%
Participación institucional
Hora de actualización: mar., 4 de mar
Hora de actualización: mar., 4 de mar
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
311
121.05M
95.42%
-4.67M
2024Q4
344
121.01M
95.72%
-4.65M
2024Q3
354
109.09M
82.30%
-7.23M
2024Q2
369
107.79M
81.32%
-6.45M
2024Q1
374
102.47M
77.65%
-12.90M
2023Q4
378
102.14M
77.80%
-10.89M
2023Q3
390
113.75M
86.92%
-11.36M
2023Q2
400
112.98M
86.34%
-14.25M
2023Q1
400
117.68M
90.49%
-17.51M
2022Q4
400
121.78M
93.79%
-42.01M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Soleus Capital Management, L.P.
12.48M
9.84%
+645.00K
+5.45%
Dec 31, 2024
Nussdorf (Glenn H)
11.91M
9.39%
--
--
Jan 09, 2025
Morgan Stanley & Co. LLC
11.75M
9.26%
-139.57K
-1.17%
Dec 31, 2024
Ades (Alan A)
11.19M
8.82%
-1.00
-0.00%
Jan 09, 2025
Erani (Dennis)
10.04M
7.92%
--
--
Jan 09, 2025
Organo PFG LLC
8.28M
6.53%
--
--
Jan 09, 2025
RED Holdings, L.L.C.
6.78M
5.35%
--
--
Jan 09, 2025
BlackRock Institutional Trust Company, N.A.
4.75M
3.74%
-23.82K
-0.50%
Dec 31, 2024
The Vanguard Group, Inc.
3.59M
2.83%
-82.64K
-2.25%
Dec 31, 2024
Acadian Asset Management LLC
3.08M
2.43%
+65.66K
+2.17%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: mar., 6 de may
Hora de actualización: mar., 6 de may
Nombre
Proporción
WisdomTree US SmallCap Fund
0.12%
iShares Micro-Cap ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
Franklin US Small Cap Multifactor Index ETF
0.04%
DFA Dimensional US Small Cap Value ETF
0.03%
Avantis US Small Cap Equity ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.03%
SPDR S&P Biotech ETF
0.03%
iShares Russell 2000 Value ETF
0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
0.02%
Ver más
WisdomTree US SmallCap Fund
Proporción0.12%
iShares Micro-Cap ETF
Proporción0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.06%
Franklin US Small Cap Multifactor Index ETF
Proporción0.04%
DFA Dimensional US Small Cap Value ETF
Proporción0.03%
Avantis US Small Cap Equity ETF
Proporción0.03%
Fidelity Enhanced Small Cap ETF
Proporción0.03%
SPDR S&P Biotech ETF
Proporción0.03%
iShares Russell 2000 Value ETF
Proporción0.02%
Invesco FTSE RAFI US 1500 Small-Mid ETF
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos